MAM
MGNX icon

Meeder Asset Management’s MacroGenics MGNX Stock Holding History

Meeder Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-118
Closed -$2K – 1857
2021
Q3 		$2K Sell
118
-2,189
-95% -$52.7K ﹤0.01% 2200
2021
Q2 		$62K Buy
+2,307
New +$67.6K ﹤0.01% 1055
2020
Q4 		– Sell
-3,707
Closed -$92K – 2072
2020
Q3 		$92K Sell
3,707
-38
-1% -$1.04K 0.01% 806
2020
Q2 		$104K Buy
3,745
+2,670
+248% +$46.4K 0.01% 757
2020
Q1 		$6K Buy
1,075
+715
+199% +$6.49K ﹤0.01% 1719
2019
Q4 		$4K Buy
+360
New +$3.56K ﹤0.01% 1851
2019
Q1 		– Sell
-12,033
Closed -$153K – 1793
2018
Q4 		$153K Buy
12,033
+11,790
+4,852% +$198K 0.01% 561
2018
Q3 		$5K Buy
243
+5
+2% +$107 ﹤0.01% 1331
2018
Q2 		$4.92K Buy
238
+171
+255% +$3.85K ﹤0.01% 1279
2018
Q1 		$2K Buy
+67
New +$1.63K ﹤0.01% 1381
2017
Q3 		– Sell
-222
Closed -$4K – 1705
2017
Q2 		$4K Buy
222
+67
+43% +$1.28K ﹤0.01% 1259
2017
Q1 		$3K Buy
155
+103
+198% +$1.99K ﹤0.01% 1267
2016
Q4 		$1K Buy
+52
New +$1.31K ﹤0.01% 957

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Meeder Asset Management's MGNX Position: Q4 2021 in Review

Meeder Asset Management sold out of MacroGenics (MGNX) in Q4 2021, closing a stake of 118 shares — an estimated $2K sold.

Meeder Asset Management first reported a position in MGNX in Q4 2016 and held it in 13 quarters. The position peaked at $153K in Q4 2018. 156 funds tracked by Wall St. Rank hold MGNX as of Q4 2021.

  • Meeder Asset Management reported no remaining MacroGenics position as of Q4 2021 after selling out during the quarter.
  • Meeder Asset Management sold 118 MacroGenics shares in Q4 2021, an estimated $2K.
  • Meeder Asset Management first reported a position in MacroGenics in Q4 2016 and held it in 13 quarters.
  • Meeder Asset Management's MacroGenics position peaked at $153K in Q4 2018.
  • 156 funds tracked by Wall St. Rank held MacroGenics as of Q4 2021.

Based on Meeder Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.